☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Released
Henlius Presents P-III Data of HLX04 (biosimilar- bevacizumab) at CSCO 2020
September 20, 2020
The US FDA Released Draft Guidelines for Proposed Biosimilar or Proposed Interchangeable Biosimilars
February 7, 2020
Conglomerate of Rheumatology and Spondylitis Organizations Released New Updated Guidelines Against Mandatory Switching to Biosimil...
August 22, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.